The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance. Glob. Scie. Revi. 2026;48:42-45. Accessed May 6, 2026. https://scienticreview.com/index.php/gsr/article/view/602